Objective: To provide additional information on clinical and echocardiographic outcomes after reimplantation of the aortic valve (RAV) in patients with aortic root aneurysm.
See Editorial Commentary page 239.
See Editorial page 230.
Reimplantation of the aortic valve (RAV) into a cylindrical Dacron graft is an alternative operation to composite replacement of the aortic valve and ascending aorta (Bentall operation) in patients with an aortic root aneurysm with or without associated genetic syndromes and with normal or near-normal aortic cusps. 1 Whether RAV offers a survival advantage over the Bentall procedure in the treatment of aortic root aneurysms remains controversial. RAV certainly is associated with lower rates of hemorrhage and thromboembolism 2, 3 ; however, it also may be associated with an unacceptably high rate of aortic regurgitation (AR), which eventually leads to the need for reoperation.
RAV is a complex operation, altering the geometry of the aortoventricular junction, the crescent shape of each cusp attachment to the aortoventricular junction, the heights of the commissures, and the diameter of the sinotubular junction. In addition, numerous technical modifications have been introduced over the years, some of questionable value. The original RAV was done with a cylindrical Dacron graft, and this has provided the best clinical outcomes and the most stable aortic valve function. 6 The present study is an update of the clinical outcomes of RAV performed mostly in young adults with aortic root aneurysm who have been followed prospectively with periodical images of the aortic valve and aorta since we introduced this operation in 1989. 6 
PATIENTS AND METHODS
Between August 3, 1989 , and December 31, 2012, 333 consecutive patients with aortic root aneurysm underwent RAV at Toronto General Hospital (Tables 1 and 2 ). The aortic valve was reimplanted into a straight tubular Dacron graft in 216 patients and into a graft surgically tailored to create neo-aortic sinuses in 117 patients. Intraoperative transesophageal echocardiography was used, and all patients underwent transthoracic echocardiography before hospital discharge. Echocardiographic studies were requested every year during the first decade after surgery and less frequently thereafter. Approximately one-half of these studies were performed in our hospital, and the remainder were performed in external laboratories by registered cardiac sonographers under supervision of a cardiologist. Quantification of AR was based on comprehensive interpretation of all specific, supportive, and quantitative measurements as recommended by the American Society of Echocardiography. 7, 8 Patients who underwent concomitant mitral valve repair or developed atrial fibrillation postoperatively received anticoagulant therapy with warfarin sodium during the first 3 months after surgery. All other patients were prescribed aspirin (81 mg/day). Patients with syndromic aortic root aneurysm or aortic dissection were given a beta-blocker postoperatively.
The follow-up was closed on December 31, 2015, for this report. At that time, we had clinical information for all patients and recent (<2 years) echocardiographic data for all but 6 international patients, for whom no study had been done during the most recent 5-year period. The mean follow-up was 10.3 AE 6.8 years (range, 3-25 years). This study was approved by the Review Ethics Board of University Health Network.
Statistical Analysis
Data are reported as mean with standard deviation, median with interquartile range (25th-75th percentile), or frequency as appropriate. Freedom from mortality was calculated using Kaplan-Meier survival estimates. Freedom from time-dependent outcomes other than mortality and moderate and severe AR was calculated using the cumulative incidence function, accounting for the competing risks of mortality and the outcome of interest. Univariable risk factor analysis was performed on the cumulative incidence function using Cox regression, and hazard ratios (HRs) with 95% confidence intervals (CIs) and P values are reported. Preoperative variables with a univariable P value < .25 were tested in a multivariable model using Cox regression and HRs to determine the independent predictors of postoperative adverse events. Given that the presence of AR can be captured only intermittently at the time of echocardiography, the time of AR cannot be measured precisely. As a result, we treated time to develop moderate and severe AR as an interval-censored outcome. We used the competing-risk method with interval censoring as suggested by Leffrondr_ e et al, 9 and conducted analyses (modeling and risk factor analysis with the Fine-Gray method) using R with the MHCD package. 10 In addition, we used serial echocardiography data to create a longitudinal ordinal logistic regression model to determine the progression of AR over time. Time since initial operation was modeled as a third-order polynomial function, and an autoregressive covariance structure was used to adjust for the correlation between the multiple echocardiograms available for each patient (both options selected based on the quasi-Akaike information criterion). Estimates of the proportion of patients in each of the different aortic valve functional states over time were adjusted to take into consideration the proportion of patients who had died or had undergone reoperation. Unless noted otherwise, analyses were performed using SAS 9.4 (SAS Institute, Cary, NC).
RESULTS

Early Mortality and Morbidity
Four deaths occurred during the first 90 days after surgery. The causes of death were low cardiac output syndrome due to perioperative myocardial infarction in 1 patient, acute type B aortic dissection with malperfusion of the splanchnic vessels on the day after surgery in 1 patient with Marfan syndrome, Clostridium difficile colitis in 1 patient while in a convalescence hospital at 3 weeks after surgery, and stroke likely due to atrial fibrillation in 1 patient at home 6 weeks after surgery.
Reexploration of the mediastinum for bleeding or tamponade was performed in 29 patients (8.7%). Four patients underwent early cardiac reoperation on cardiopulmonary bypass: 1 with Bentall procedure for moderate AR, likely owing to an incorrectly performed operation (our case 2); 1 for reexploration of the aortic root and coronary artery buttons because of refractory ventricular fibrillation; 1 with mitral valve repair for perforation of the anterior leaflet of the mitral valve by the aortic annuloplasty suture, and 1 with mitral valve re-repair owing to systolic anterior motion of the anterior leaflet. In the patients who underwent reexploration of the aortic root and coronary artery buttons, a large amount of white clots in all 3 aortic sinuses was found, which histological examination revealed to be mostly platelets; the circulating blood was totally depleted from platelets, and heparininduced thrombocytopenia tests were negative. Laparotomy for repair of a ruptured liver was done in 1 patient. All 5 patients survived. Four patients experienced perioperative myocardial infarction, 1 of whom died. Five patients underwent implantation of a permanent transvenous pacemaker; among these patients, 2 developed renal failure requiring temporary dialysis, 3 had a superficial wound infection, and 1 patient had a deep sternal infection. Thirtyone patients required assisted ventilation for more than 24 hours. New transient atrial fibrillation developed in 67 patients (20.1%), and transfusion of any blood product was necessary in 167 patients (50%).
Late Mortality and Morbidity
There were 35 late deaths: 4 sudden, 6 due to complications of aortic dissection, 2 due to myocardial infarction, 2 due to heart and renal failure, and 21 Eight patients sustained a stroke, 2 of whom died. Four of these 8 patients were on warfarin, therapy, 2 were on aspirin therapy, and 2 were on no antithrombotic therapy. Nine patients experienced transient ischemic attack, 6 of whom were receiving aspirin therapy. The freedom from stroke and transient ischemic attacks at 10, 15, and 20 years was 95.0 AE 1.4%, 92.5 AE 2.8%, and 92.5 AE 2.8%, respectively. Age (by 5-year increments) was the sole factor associated with stroke or transient ischemic attack (HR, 1.308; 95% CI, 1.081-1.583; P ¼ .006).
One patient developed infective endocarditis of the aortic valve with aortic root abscess due to Staphylococcus aureus at 23 years after RAV and underwent aortic root replacement with an aortic homograft. Two patients developed infective endocarditis of the mitral valve; 1 of these patients required mitral valve repair, and the other was treated successfully with antibiotics alone. These 3 patients survived.
Eight patients developed moderate AR and 3 developed severe AR postoperatively. Using interval censoring, freedom from moderate and severe AR was 98.0 AE 0.5% at 5 years and 96.2 AE 1.0% at 10, 15 and 20 years. Using time of echocardiography as the time of event, these percentages were 95.4 AE 1.7% at 10 years, 92.3 AE 2.8% at 15 years, and 92.3 AE 2.8% at 20 years. Progression of AR over time using serial echocardiography data is depicted in Figure 2 , and the relevant data are presented in Table 3 . Creation of neo-aortic sinuses (HR, 1.87; 95% CI, 1.02-3.42; P ¼ .04) and reinforcement of the free margin of the cusps with Gore-Tex sutures (HR, 3.25; 95% CI, 1.42-7.41; P ¼ .005) were associated with the development of moderate or severe AR on univariable analysis, but not on multivariable analysis. Cusp plication was not statistically associated with the development of moderate or severe AR (HR, 1.43; 95% CI, 10-81-2.53;
Six patients underwent reoperation on the aortic valve between 2 days and 23 years after the initial surgery, including 1 for endocarditis and 5 for AR. One patient developed a perforation of the right coronary cusp without obvious explanation, which was repaired by H. J. Sch€ afers at 6 months after RAV (personal communication). One patient needed coronary artery bypass, and because of his AR, the aortic valve was replaced at the same time in Athens, Greece, at 9 years after RAV. Three patients underwent aortic valve replacement because of moderate or severe AR in our hospital, 1 each at 2 days, 8 years, and 9 years after RAV. The first of these replacements was required because of a technical error, and the latter 2 were necessary because of degenerative changes in the cusps of the aortic valve (1 bicuspid and 1 tricuspid). All patients survived reoperation. Freedom from aortic valve reoperation at 10, 15, and 20 years was 96.9 AE 1.3%. In addition to the aortic valve reoperations, 1 patient underwent total arch replacement with an elephant trunk for chronic type A aortic dissection, 3 patients underwent mitral valve repair, and 1 patient underwent replacement of the thoracoabdominal aorta for chronic dissecting aneurysm.
Before RAV, 28 patients had acute type A aortic dissection, and 3 had chronic type B aortic dissection (14 with Marfan syndrome, 1 with Loeys-Dietz syndrome, and 16 with nonsyndromic aortic root aneurysm). Five of these 31 patients died due rupture of the false lumen. After RAV, 11 patients developed new type B aortic dissection, and 1 patient developed dissection of the aortic arch, with 2 deaths due to malperfusion. Nine of the patients who developed new aortic dissection had Marfan syndrome. All patients with Marfan syndrome were on beta-blocker therapy when the new dissection occurred. At the last followup contact, 283 patients were alive and free from reoperation on the aortic valve: 255 (90%) were in New York Heart Association functional class I, 24 (8.5%) were in class II, and 4 (1.4%) were in class III.
DISCUSSION
Aortic root aneurysm in young patients usually starts with dilatation of the aortic sinuses. Over time, the dilatation extends proximally into the aortoventricular junction and distally into the sinotubular junction. These aneurysms are often associated with genetic syndromes. Aortic root aneurysms in older patients is often a consequence of a degenerative process that starts with dilatation of the ascending aorta and proceeds with the dilatation extending proximally into the sinotubular junction and aortic sinuses, but seldom affecting the aortoventricular junction. Clinical experience has shown that remodeling of the aortic root is associated with a high failure rate when performed in the former type of aortic root aneurysm, but not in the latter type. 1, [11] [12] [13] [14] The principal cause of failure of the remodeling procedure in patients with aortic root aneurysm associated with a genetic syndrome is dilatation of the aortoventricular junction many years after surgery 13, 14 ; therefore, RAV is likely the best option for preserving the aortic valve in young patients with aortic root aneurysm. Remodeling of the aortic root is a useful operation and a simpler procedure than RAV, however, and is probably the best option for preserving the aortic valve in older patients with ascending aortic aneurysm and AR secondary to dilatation of the sinotubular junction. 12, 15 A recent study from Johns Hopkins Hospital 2 compared the late outcomes of aortic valve-sparing operations (69 patients with RAVand 29 with remodeling) with Bentall (67 patients) and found equivalent results in terms of survival, risk of reoperation, and endocarditis, but ''significantly fewer thromboembolic and hemorrhagic events.'' Hopkins' surgeons favor RAV in patients with normal aortic cusps. 2 We compared outcomes in 253 patients who underwent aortic valve-sparing operations, 180 patients who received a replacement tissue valve, and 183 patients who received a replacement mechanical valve. 3 After adjusting for clinical covariates, the aortic valve-sparing operation was associated with reduced cardiac mortality and valve-related complications compared with aortic root replacement with a mechanical or tissue valve. 3 Ideal patients for RAV have a relatively small aortic root (<55 mm), no AR, and grossly normal cusps on surgical inspection. These patients should have no more trace AR after RAV in the operating room; if they do, it is usually due to technical error. Malaligned aortoventricular junction inside the graft, altered contour of the crescent-shaped aortic annulus, cusp prolapse, and incorrect graft size are the most frequent causes of early AR. In our experience with 333 consecutive patients who underwent RAV, only 11 patients developed moderate or severe AR during a mean follow-up of 10 years. Cusp reinforcement with Gore-Tex sutures and the creation of neo-aortic sinuses were associated with an increased risk of moderate or severe AR on univariable analysis but not on multivariable analysis. The challenge here was that we had only 11 events, which means that numerous factors were close to significant and would likely be significant with more events. In addition, 18 patients exhibited mild to moderate AR on some echocardiograms but not others, hindering interpretation of the degree of AR. Thus, further follow-up is needed to determine the factors associated with progression of AR.
A recent multicenter study showed that any AR occurring soon after RAV increased the risk of progressive AR and eventually the likelihood of reoperation. 4 As illustrated in Figure 2 , almost one-fourth of our patients left the hospital with mild AR, but only 3 progressed to moderate AR, and we could not establish a relationship between the degree of AR on hospital discharge and the development of moderate or severe AR during follow-up. We believe that more important than the absence of trivial or mild AR at the completion of RAV is the geometry of the aortic cusps, coaptation height, and coaptation length, as described by Kunihara et al. 16 The use of commercially available Dacron grafts with aortic sinuses, such as the Gelweave Valsalva (Vascutek, Renfrewshire, UK) or the Cardioroot (Atrium Medical, Hudson, NH), further complicates the performance of this operation, because their sinuses are spherical and will deform the aortoventricular junction if correctly implanted inside the graft. Another problem with these grafts is that the height of the sinuses may not coincide with height of the native aortic valve commissures, creating another technical and anatomic difficulty. De Paulis et al 5 recently published the results of RAV with the Gelweave Valsalva, which appear to be suboptimal, with approximately 10% reoperations and 13% moderate or severe AR at 10 years.
If one believes that aortic sinuses are important for the durability of this operation (something that we have not been able to prove to be beneficial), then an anatomically correct Dacron graft with neo-sinuses (Uni-Graft W SINUS; Braun, Melsungen, Germany) is now available. 17, 18 A study using 4-dimensional magnetic resonance imaging in patients who underwent RAV with this graft showed fairly normal flows with near-physiological sinus vortex formation and transvalvular pressure gradients. 19 Experience with this graft is limited to date, 17, 18 and further studies are needed to verify that it maintains its geometry after implantation, given that tubular Dacron grafts tend to increase in diameter with time, particularly in the ascending aorta, 20 and the sinuses may become spherical. This anatomically correct Dacron graft with sinuses mimics the normal aortic root and may prove to be the ideal graft for RAV; however, until that time, even with the unphysiological properties of RAV with a cylindrical Dacron graft, this remains the best and most durable operation, as documented in this report. Over the last 2 years, we have returned to the original RAV, that is, reimplantation into a cylindrical graft without creating neo-aortic sinuses. In our experience, the creation of neo-aortic sinuses appears to adversely affect the durability of RAV; however, as mentioned above, further follow-up is needed.
Another group of patients with abnormal aortic cusps that may benefit from RAV is the those with a bicuspid aortic valve with AR. 21 Patients with a bicuspid aortic valve are likely to come to surgical attention for the AR rather than for the size of the aortic aneurysm. If the aortic cusps are well developed (thin, pliable, and of adequate height), the AR is often caused by prolapse of the conjoint cusp and dilatation of the aortic annulus. Simple correction of the cusp prolapse and subcommissural plication to reduce the diameter of the aortic annulus has not provided lasting results. 22 A surgical group from Brussels has reported better clinical outcomes when these valves are treated with RAV. 21 We agree with their approach when the aortic sinuses are >40 mm, but consider it an aggressive procedure if the aortic sinuses are normal. In these patients, we prefer to combine cusp repair with an external annuloplasty band to correct the dilated aortic annulus, similar to what we have described for the remodeling procedure. 23 RAV also has been performed in patients with acute type A aortic dissection. Surgery for acute aortic dissection remains challenging and humbling even for experienced surgeons, and continues to be associated with high operative mortality and morbidity. Adding RAV at the time of surgery for acute dissection, which is primarily intended to save the patient's life, might not be the best approach, except perhaps in the hands of experienced aortic surgeons.
Dilatation of the pulmonary autograft is the principal mode of failure of the Ross procedure, and if the autograft cusps are normal, then an aortic valve-sparing operation can be performed. 24 A recent multicenter study from Europe including 86 patients with a failed Ross procedure who had an aortic valve-sparing operation showed a freedom from reoperation of only 76% at 8 years. 24 We consider this an suboptimal result, and believe that only patients with normal pulmonary autograft cusps should be subjected to an aortic valve-sparing operation.
This present study has several limitations, most importantly the lack of accurate criteria for patient selection for RAV and the fact that all operations were performed by only 2 experienced aortic surgeons. For these reasons, the results presented might not be generalizable. Of possible importance is the fact that we have been relatively conservative when it comes to RAV. We did not use any patch augmentation of cusps in this series, and most patients had normal or near-normal cusps at the time of surgery.
CONCLUSIONS
RAV has been performed for more than 2 decades, and the long-term results have been excellent in our experience. The risk of AR after surgery is low, probably lower than with any other type of valve repair. This operation has made a major difference in the lives of young adults with aortic root aneurysms.
